Amlodipine/valsartan (Exforge) is an oral medication used to treat hypertension (high blood pressure). Learn about side effects, warnings, dosage, and more.

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

Amlodipine and Valsartan Tablets are available in 5mg/160mg, 10mg/160mg, 5mg/320mg, and 10mg/320mg strengths. Par has begun shipment of this product. For more information call (800) 828-9393 or ...

The US FDA has approved the first combination of an angiotensin receptor blocker—valsartan—with a calcium blocker—amlodipine—for the initial treatment of hypertension. The ...

The EU has approved valsartan plus amlodipine besylate tablets (Exforge) and a new indication for sunitinib malate capsules (Sutent); Canada has approved hepatitis B immune globulin [human ...

Amlodipine (as besylate) 5 mg, valsartan 160 mg; tabs. Exforge combines two antihypertensive drugs that have complementary mechanisms of action: amlodipine, a calcium (Ca+) channel blocker, and ...

Review the side-effects of Amlodipine and Valsartan as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Find out how to take Amlodipine and Valsartan(drug) and its dose. ... Brand Names or Trade Names of Amlodipine and Valsartan International : Exforge . Last Updated on Nov 08, 2024 .

Novartis has said it will pay $245 million to resolve civil litigation in the US, which accuses it of a 'pay for delay' scheme involving generics of its high blood pressure therapy Exforge. The ...

EXFORGE HCT 5/160/25 (5 mg amlodipine, 160 mg valsartan and 25 mg hydrochlorothiazide) tablets are yellow, ovaloid, biconvex with bevelled edge and imprinted with NVR on one side and VEL on the other.

Novartis has been boosted by data from a new study which shows that its new combination antihypertensive Exforge lowers blood pressure in twice as many patients than those on amlodipine alone. Exforge ...

Testing revealed that valsartan contained trace amounts of N-nitrosodiethylamine, or NDEA, a possible human carcinogen, the company said. Amlodipine and hydrochlorothiazide in standalone form are ...